Simvastatin induces heme oxygenase-1 - A novel mechanism of vessel protection

被引:238
作者
Lee, TS [1 ]
Chang, CC [1 ]
Zhu, Y [1 ]
Shyy, JYJ [1 ]
机构
[1] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA
关键词
vasculature; statins; muscle; smooth;
D O I
10.1161/01.CIR.0000140694.67251.9C
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Evidence from experimental and clinical studies indicates that statins can protect the vessel wall through cholesterol-independent mechanisms. The "pleiotropic" effects include the prevention of inflammation and proliferation of vascular cells. Here, we studied whether heme oxygenase-1 (HO-1), an important cytoprotective molecule, is induced by simvastatin and the role of HO-1 in the pleiotropic effects of simvastatin. Methods and Results-Human and rat aortic smooth muscle cells treated with simvastatin showed an elevated level of HO-1 for up to 24 hours. The induction of HO-1 by simvastatin was not found in cultured endothelial cells and macrophages. Injecting C57BL/6J mice intraperitoneally with simvastatin increased the level of HO-1 in vascular SMCs (VSMCs) in the tunica media. Treating VSMCs with zinc protoporphyrin, an HO-1 inhibitor, or HO-1 small interfering RNA (siRNA) blocked the antiinflammatory effect of simvastatin, including the inhibition of nuclear factor-kappaB activation and nitric oxide production. Blockade of HO-1 also abolished the simvastatin-induced p21(Waf1) and the associated antiproliferative effect. Simvastatin activated p38 and Akt in VSMCs, and the respective inhibitor of p38 and phosphoinositide 3-kinase (PI3K) greatly reduced the level of simvastatin-induced HO-1, which suggests the involvement of p38 and the PI3K-Akt pathway in HO-1 induction. Conclusions-Simvastatin activates HO-1 in VSMCs in vitro and in vivo. The antiinflammatory and antiproliferative effects of simvastatin occur largely through the induced HO-1.
引用
收藏
页码:1296 / 1302
页数:7
相关论文
共 28 条
[1]  
Alam J, 2000, J BIOL CHEM, V275, P27694
[2]   HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells [J].
Bourcier, T ;
Libby, P .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (02) :556-562
[3]   Heme oxygenase-1-derived carbon monoxide requires the activation of transcription factor NF-κB to protect endothelial cells from tumor necrosis factor-α-mediated apoptosis [J].
Brouard, S ;
Berberat, PO ;
Tobiasch, E ;
Seldon, MP ;
Bach, FH ;
Soares, MP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (20) :17950-17961
[4]   Relation of inflammation and benefit of statins after percutaneous coronary interventions [J].
Chan, AW ;
Bhatt, DL ;
Chew, DP ;
Reginelli, J ;
Schneider, JP ;
Topol, EJ ;
Ellis, SG .
CIRCULATION, 2003, 107 (13) :1750-1756
[5]  
Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3
[6]   3-hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/p21 signaling pathway: Implications for diabetic nephropathy [J].
Danesh, FR ;
Sadeghi, MM ;
Amro, N ;
Philips, C ;
Zeng, LX ;
Lin, S ;
Sahai, A ;
Kanwar, YS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (12) :8301-8305
[7]   HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells [J].
Dichtl, W ;
Dulak, J ;
Frick, M ;
Alber, HF ;
Schwarzacher, SP ;
Ares, MPS ;
Nilsson, J ;
Pachinger, O ;
Weidinger, F .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (01) :58-63
[8]   Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].
Downs, JR ;
Clearfield, M ;
Weis, S ;
Whitney, E ;
Shapiro, DR ;
Beere, PA ;
Langendorfer, A ;
Stein, EA ;
Kruyer, W ;
Gotto, AM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622
[9]   Heme oxygenase-1 protects against vascular constriction and proliferation [J].
Duckers, HJ ;
Boehm, M ;
True, AL ;
Yet, SF ;
San, H ;
Park, JL ;
Webb, RC ;
Lee, ME ;
Nabel, GJ ;
Nabel, EG .
NATURE MEDICINE, 2001, 7 (06) :693-698
[10]   Pleiotropic effects of statins: do they matter? [J].
Gotto, AM ;
Farmer, JA .
CURRENT OPINION IN LIPIDOLOGY, 2001, 12 (04) :391-394